证券代码：603009 证券简称：北特科技 公告编号：2026-015 上海北特科技集团股份有限公司 关于注销公司部分股份暨通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 （一）债权申报所需材料 公司债权人可持证明债权债务关系存在的合同、协议及其他凭证的原件及复印件到公司申报债权。 1、债权人为法人的，需同时携带法人营业执照副本原件及复印件、法定代表人身份证明文件并加盖公 章；委托他人申报的，除前述文件外，还需携带法定代表人授权委托书和代理人有效身份证件的原件及 复印件。 2、债权人为自然人的，需同时携带有效身份证件的原件及复印件；委托他人申报的，除前述文件外， 还需携带授权委托书和代理人有效身份证件的原件及复印件。 一、通知债权人的原由 上海北特科技集团股份有限公司（以下简称"公司"）于2026年2月10日、2月26日分别召开了第六届董事 会第五次会议、2026年第一次临时股东会，审议通过了《关于变更注册资本并修订〈公司章程〉的议 案》，因公司子公司上海光裕汽车空调压缩机有限公司（现已更名为"上海北特光裕新 ...

重要内容提示： ■ 一、回购审批情况和回购方案内容 2025年1月27日，上海吉祥航空股份有限公司（以下简称"公司"）第五届董事会第十五次会议审议通过 了《关于以集中竞价交易方式回购公司股份方案的议案》，同意公司以自有资金及自筹资金（含银行回 购专项贷款）通过集中竞价交易方式回购公司股份，并将回购股份全部用于员工持股计划或股权激励。 回购资金总额不低于人民币25,000万元（含，下同），不超过人民币50,000万元（含，下同），回购价 格不超过人民币15.80元/股（含），回购期限为自董事会审议通过回购股份方案之日起12个月内。详见 公司于2025年2月6日、2025年2月13日披露的《上海吉祥航空股份有限公司关于以集中竞价交易方式回 购股份方案的公告》（公告编号：2025-006）、《上海吉祥航空股份有限公司关于以集中竞价交易方式 回购股份的回购报告书》（公告编号：2025-011）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 公司分别于2025年4月18日、2025年5月12日召开公司第五届董事会第十六次会议及202 ...

关于注销回购股份的实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ●杭萧钢构股份有限公司（以下简称"公司"）于2025年10月30日、2025年11月18日分别召开了第九届董 事会第四次会议、第九届监事会第三次会议及2025年第四次临时股东大会，审议通过了《关于变更回购 股份用途并注销暨减少注册资本的议案》，拟将存放于回购专用证券账户中已回购但尚未使用的 9,997,714股股份变更用途并实施注销。注销完成后，公司总股本将由2,368,966,150股减少为 2,358,968,436股，公司注册资本将由人民币2,368,966,150元减少为2,358,968,436元。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600477 证券简称：杭萧钢构（维权） 公告编号：2026-007 杭萧钢构股份有限公司 股本的比例约为0.42%。注销完成后，公司总股本将由2,368,966,150股变更为2,358,968,436股，公司注 册资本将由人民币2,368,966,150元变更为2,3 ...

Core Viewpoint - The company plans to cancel 9,997,714 shares that were repurchased but not used, which will reduce its total share capital and registered capital without affecting its listing status or harming investor interests [1] Group 1: Share Cancellation Details - The shares to be canceled were repurchased in 2022 at a total cost of 36.4776 million yuan [1] - The cancellation will reduce the total share capital from 2,368,966,150 shares to 2,358,968,436 shares [1] - The registered capital will decrease from 2,368,966,150 yuan to 2,358,968,436 yuan following the cancellation [1] Group 2: Approval Process - The board of directors, supervisory board, and shareholders' meeting approved the change of purpose and cancellation on October 30 and November 18, 2025 [1]

Core Viewpoint - The company announced a share repurchase plan initiated in March 2022, with a total expenditure of 199 million yuan for repurchasing shares for employee stock ownership plans and later changing the purpose to equity incentives [1] Group 1: Share Repurchase and Usage - In March 2022, the company decided to repurchase shares amounting to 150 to 300 million yuan for employee stock ownership plans [1] - As of March 2023, the company had repurchased a total of 18.38 million shares, costing 199 million yuan [1] - The purpose of the repurchased shares was later changed to equity incentives [1] Group 2: Stock Grant and Cancellation - In 2024, the company granted 12.99 million restricted shares to 289 incentive recipients, with 5.39 million shares remaining [1] - In 2025, the board and shareholders agreed to cancel the remaining shares [1] - The cancellation was completed on January 21, 2026, reducing the total share capital from 1.525 billion shares to 1.519 billion shares, without affecting the company's listing status [1]

Core Viewpoint - Loxiao Technology plans to change the purpose of its repurchased shares from employee stock ownership plans to complete cancellation, aiming to enhance shareholder value and investor confidence [1][2] Group 1: Share Repurchase and Cancellation - The company announced the cancellation of 13.83195 million shares, which represents 0.72% of its total share capital [1] - This decision is intended to maintain company value and improve earnings per share, thereby fostering long-term stable development [1] - Loxiao Technology has previously conducted two rounds of share repurchases, totaling 42.7737 million shares with an investment of approximately 275 million yuan [1] Group 2: Financial and Operational Implications - The cancellation of shares is expected to enhance capital efficiency and shareholder return levels, aligning with the company's current operational and capital structure [1] - Industry experts believe that such actions, when not affecting normal operations and financial stability, can improve earnings per share and long-term investment value, reinforcing the company's capital foundation for future growth [2]

Core Viewpoint - The company, Aorui De Optoelectronics Co., Ltd., plans to change the purpose of part of its repurchased shares from sale to cancellation, which will reduce its registered capital and total share capital [2][6][10]. Group 1: Share Repurchase Plan and Implementation - The company initially approved a share repurchase plan to maintain company value and shareholder rights, with a budget between RMB 50 million and RMB 100 million, and a maximum repurchase price of RMB 2.11 per share [2][3]. - As of September 20, 2024, the company successfully repurchased 35,721,000 shares, accounting for 1.29% of the total share capital, at an average price of RMB 1.40 per share, totaling RMB 50,025,456.20 [3]. Group 2: Change in Share Repurchase Purpose - The company intends to change the purpose of 130,000 shares from "sale through centralized bidding" to "cancellation and reduction of registered capital" [2][6]. - This change is aimed at enhancing investor confidence and increasing long-term investment value, aligning with the company's operational and financial strategies [6][7]. Group 3: Impact of Share Cancellation - Following the cancellation, the total share capital will decrease from 2,751,447,394 shares to 2,751,317,394 shares, and the registered capital will also decrease correspondingly [8][10]. - The change is expected to improve earnings per share and enhance shareholder returns without negatively impacting the company's debt servicing ability or operational continuity [7][10]. Group 4: Decision-Making Process - The board of directors approved the proposal on January 15, 2026, and it will be submitted for shareholder approval [10][11]. - The company will follow legal procedures for share cancellation and necessary registration changes, with the final results subject to regulatory approval [10].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603127 证券简称：昭衍新药 公告编号：2026-001 北京昭衍新药研究中心股份有限公司 关于员工持股计划回购股份注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 回购注销原因：北京昭衍新药研究中心股份有限公司（以下简称"公司"）已终止实施2021年及2022年 A股员工持股计划，公司拟注销回购专用账户中的A股共计129,114股。 ● 本次注销股份的有相关情况： ■ 一、本次员工持股计划回购股份注销已履行的决策程序和信息披露情况 （一）2021年A股员工持股计划 公司于2021年9月21日召开第三届董事会第二十九次会议和第三届监事会第二十次会议、于2022年1月19 日召开2022年第一次临时股东大会审议并通过了《关于公司〈2021年A股员工持股计划（草案）及其摘 要的议案》、《关于公司〈2021年A 股员工持股计划管理办法〉的议案》、《关于提请股东大会授权董 事会全权办理员工持股计划相关事宜的议案》，公司实施2021年A ...

海尔生物公告称，公司已完成部分回购股份注销，注销1,459,586股，占注销前总股本317,952,508股的 0.46%，注销日为2026年1月6日。本次注销后，公司总股本由317,952,508股减至316,492,922股，注册资 本由3.18亿元减至3.16亿元。公司于2022 - 2023年完成首次回购，使用资金9,969.37万元。此次注销是为 履行承诺、增强投资者回报，对公司经营等无重大影响。 ...

天福(06868)发布公告，2026年1月5日，该公司斥资5460港元回购2000股股份，每股回购价格为2.73港 元;2025年10月22日至2025年12月24日期间回购的股份于2026年1月5日获注销10.8万股股份。 ...